Physiological Effects of Different Preoxygenation Strategies (PREOXY II)
Physiological Effects of Different Preoxygenation Strategies in Adults and Children: A Comparative Study of NRM and BVM With and Without PEEP
The goal of this clinical trial is to evaluate the performance and physiological effects of different preoxygenation devices in healthy adult and pediatric volunteers (children aged 5-12 years). The study aims to determine how these devices influence oxygen delivery, airway pressure, and cardiopulmonary physiology during preoxygenation.
The main questions it aims to answer are:
- What fraction of inspired oxygen (FiO₂) is delivered by non-rebreather masks (NRM) compared to bag-valve masks (BVM) with and without positive end-expiratory pressure (PEEP)?
- How do these devices differ in terms of generated PEEP, inspiratory effort, and their effects on lung ventilation and cardiac function?
Researchers will compare NRM, BVM without PEEP, and BVM with PEEP (each with or without supplemental oxygen via nasal cannula) to evaluate differences in oxygenation and physiological effects.
Participants will:
- Complete multiple 3-minute preoxygenation sessions using each device in randomized order
- Breathe spontaneously through each device, with or without additional oxygen via nasal cannula
- Undergo non-invasive monitoring of oxygen concentration (FiO₂), respiratory parameters, airway pressures, and ultrasound assessment of the lungs, diaphragm, and heart
- Perform a brief breath-holding maneuver to assess airway pressure generation
調査の概要
状態
条件
介入・治療
- デバイス:Nasal cannula (NC)
- デバイス:Non-rebreather mask (NRM)
- デバイス:Non-rebreather mask (NRM) plus Nasal cannula (NC)
- デバイス:Bag-valve mask (BVM) without PEEP
- デバイス:Bag-valve mask (BVM) without PEEP + nasal cannula (NC)
- デバイス:Bag-valve mask (BVM) with PEEP
- デバイス:Bag-valve mask (BVM) with PEEP + nasal cannula (NC)
詳細な説明
Hypoxemia is a frequent and potentially life-threatening complication during advanced airway management, associated with adverse outcomes such as hypoxic brain injury, cardiovascular collapse, and death. Effective preoxygenation is essential to increase oxygen reserves and prolong safe apnea time during intubation. Although several devices are routinely used for preoxygenation, including non-rebreather masks (NRM) and bag-valve masks (BVM) with or without positive end-expiratory pressure (PEEP), important uncertainties remain regarding their actual performance and physiological effects.
Current evidence suggests that techniques providing PEEP may improve oxygenation by increasing functional residual capacity, enhancing ventilation of dependent lung regions, and reducing ventilation-perfusion mismatch. However, the relative contribution of FiO₂ delivery versus PEEP, as well as the physiological effects on respiratory mechanics and cardiovascular function, are not fully understood. In addition, it remains unclear whether BVM devices without a dedicated PEEP valve can generate measurable PEEP, and whether patients can generate sufficient inspiratory effort to effectively operate BVM valves without assisted ventilation. Data in pediatric populations are particularly limited.
This randomized crossover study is designed to systematically evaluate the performance of commonly used preoxygenation devices under controlled conditions in healthy adult and pediatric volunteers. By comparing NRM, BVM without PEEP, and BVM with PEEP-with and without supplemental oxygen via nasal cannula-the study aims to characterize differences in oxygen delivery, airway pressure generation, inspiratory effort, and their physiological impact.
The study will focus on key physiological domains, including oxygenation (FiO₂), respiratory mechanics (tidal volume, airway pressures, and diaphragm activity), lung aeration (with particular attention to dependent lung regions), and cardiovascular responses (including right ventricular dimensions and function). Measurements will be obtained using non-invasive monitoring techniques, including gas analysis and ultrasound.
The crossover design allows within-subject comparisons across all study conditions, minimizing inter-individual variability and enabling precise assessment of device-related effects. The findings of this study are expected to improve understanding of the mechanisms and physiological consequences of preoxygenation strategies, with potential implications for optimizing airway management practices in both adult and pediatric populations.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Giulia Roveri, MD
- 電話番号:+390471055115
- メール:giulia.roveri@eurac.edu
研究連絡先のバックアップ
- 名前:Simon Rauch, MD, PhD
- 電話番号:+390471055544
- メール:simon.rauch@eurac.edu
研究場所
-
-
BZ
-
Bolzano、BZ、イタリア、39100
- 募集
- Eurac research, Institute of mountain emergency medicine
-
コンタクト:
- Giulia Roveri, MD
- 電話番号:+390471055115
- メール:giulia.roveri@eurac.edu
-
コンタクト:
- Simon Rauch, MD, PhD
- 電話番号:+390471055544
- メール:simon.rauch@eurac.edu
-
副調査官:
- Ruth Martintoni
-
主任研究者:
- Simon Rauch, MD, PhD
-
主任研究者:
- Giulia Roveri, MD
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Adults with an American Society of Anesthesiologists (ASA) physical status score ≤ 2
- Children aged 5 to 12 years with an ASA physical status score ≤ 2
- Ability (or legal guardian ability) to provide written informed consent
Exclusion Criteria:
- Children aged < 5 years or 13 to 18 years
- ASA physical status score > 2
- Body mass index (BMI) ≥ 30 kg/m²
- Known airway pathology or anatomical abnormality that could affect mask fit, ventilation, or oxygenation
- Presence of an active airway infection at the time of the study
- Pregnancy
- Refusal or inability to provide informed consent
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Nasal Cannula (NC)
Preoxygenation over 3 minutes with a nasal cannula (NC) with supplemental oxygen delivered at 15 L/min, during spontaneous breathing.
|
Preoxygenation performed using a nasal cannula delivering supplemental oxygen at a flow rate of 15 L/min, without the use of an additional mask or ventilation device, during spontaneous breathing.
|
|
実験的:Non-rebreather facemask (NRM)
Preoxygenation over 3 minutes with a Non-rebreather facemask (NRM) with supplemental oxygen delivered at 15 L/min, during spontaneous breathing.
|
Preoxygenation performed using a non-rebreather mask with reservoir, delivering oxygen at a flow rate of 15 L/min.
The mask is fitted to ensure an optimal seal, and participants breathe spontaneously without assisted ventilation.
|
|
実験的:Non-rebreather facemask (NRM) plus Nasal Cannula (NC)
Preoxygenation for 3 minutes using a non-rebreather mask (NRM) combined with a nasal cannula delivering supplemental oxygen at 15 L/min for each device, during spontaneous breathing.
|
Preoxygenation performed using a non-rebreather mask with reservoir, delivering oxygen at a flow rate of 15 L/min, combined with a nasal cannula delivering supplemental oxygen at 15 L/min.
The mask is fitted to ensure an optimal seal, and participants breathe spontaneously without assisted ventilation.
|
|
実験的:Bag valve mask (BVM)
Preoxygenation for 3 minutes using a bag-valve-mask (BVM) with supplemental oxygen delivered at 15 L/min, during spontaneous breathing.
|
Preoxygenation performed using a bag-valve mask without a PEEP valve, delivering oxygen at a flow rate of 15 L/min.
The mask is held with a two-handed technique to ensure an airtight seal, without providing assisted ventilation, allowing spontaneous breathing.
|
|
実験的:Bag valve mask (BVM) plus Nasal cannula (NC)
Preoxygenation for 3 minutes using a bag -valve-mask (BVM) combined with a nasal cannula delivering supplemental oxygen at 15 L/min for each device, during spontaneous breathing.
|
Preoxygenation performed using a bag-valve mask without a PEEP valve, delivering oxygen at a flow rate of 15 L/min, combined with a nasal cannula delivering supplemental oxygen at 15 L/min.
The mask is held with a two-handed technique to ensure an airtight seal, without providing assisted ventilation, allowing spontaneous breathing.
|
|
実験的:Bag valve mask (BVM) plus PEEP
Preoxygenation for 3 minutes using a bag-valve mask (BVM) with positive end-expiratory pressure (PEEP) set at 10 cmH₂O and supplemental oxygen delivered at 15 L/min, during spontaneous breathing.
|
Preoxygenation performed using a bag-valve mask equipped with a PEEP valve set at 10 cmH₂O, delivering oxygen at a flow rate of 15 L/min.
The mask is held with a two-handed technique to ensure an airtight seal, without assisted ventilation, during spontaneous breathing.
|
|
実験的:Bag valve mask (BVM) plus PEEP plus Nasal Cannula (NC)
Preoxygenation for 3 minutes using a bag-valve mask (BVM) with positive end-expiratory pressure (PEEP) set at 10 cmH₂O, combined with a nasal cannula delivering supplemental oxygen at 15 L/min for each device, during spontaneous breathing.
|
Preoxygenation performed using a bag-valve mask equipped with a PEEP valve set at 10 cmH₂O, delivering oxygen at a flow rate of 15 L/min, combined with a nasal cannula delivering supplemental oxygen at 15 L/min.
The mask is held with a two-handed technique to ensure an airtight seal, without assisted ventilation, during spontaneous breathing.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Difference in fraction of inspired oxygen (FiO₂) between preoxygenation devices
時間枠:During each 3-minute preoxygenation session
|
Fraction of inspired oxygen (FiO₂) delivered during preoxygenation will be continuously measured at the airway opening using a gas analyzer.
FiO₂ values will be recorded breath-by-breath during each 3-minute preoxygenation session under all study conditions.
The primary outcome is the difference in mean FiO₂ achieved between the different preoxygenation devices (non-rebreather mask, bag-valve mask without PEEP, and bag-valve mask with PEEP), with and without supplemental oxygen via nasal cannula.
|
During each 3-minute preoxygenation session
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Positive end-expiratory pressure (PEEP) generated during preoxygenation
時間枠:During each 3-minute preoxygenation session
|
Airway pressures will be continuously measured to quantify the presence and magnitude of PEEP generated during preoxygenation with bag-valve mask (BVM) with and without a dedicated PEEP valve, with and without nasal cannula oxygen supplementation.
|
During each 3-minute preoxygenation session
|
|
Inspiratory effort required to open the BVM valve
時間枠:During each 3-minute preoxygenation session
|
The negative pressure required to open the BVM valve will be measured using airway pressure monitoring, and diaphragm ultrasound parameters (thickening fraction and excursion) will be used as surrogate markers of inspiratory effort.
|
During each 3-minute preoxygenation session
|
|
Ventilation of dependent lung regions
時間枠:During each 3-minute preoxygenation session
|
Lung ultrasound will be used to assess regional ventilation of dependent lung areas, with findings quantified using a validated scoring system to compare the effects of preoxygenation with and without PEEP.
|
During each 3-minute preoxygenation session
|
|
Correlation between FiO₂ and tidal volume
時間枠:During each 3-minute preoxygenation session
|
The relationship between fraction of inspired oxygen (FiO₂) and tidal volume during preoxygenation will be assessed using continuous, breath-by-breath measurements.
|
During each 3-minute preoxygenation session
|
|
Cardiac output
時間枠:Baseline and at the end of each 3-minute preoxygenation session
|
Changes in cardiac output (l/min/m²) will be assessed using echocardiography before and after preoxygenation to evaluate the hemodynamic effects of different devices and PEEP.
|
Baseline and at the end of each 3-minute preoxygenation session
|
|
Changes in right ventricular dimensions
時間枠:Baseline and at the end of each 3-minute preoxygenation session
|
Changes in right ventricular dimensions (mm) will be assessed using echocardiography before and after preoxygenation to evaluate the hemodynamic effects of different devices and PEEP.
|
Baseline and at the end of each 3-minute preoxygenation session
|
|
Right ventricular strain
時間枠:Baseline and at the end of each 3-minute preoxygenation session
|
Changes in right ventricular strain (%) will be assessed using echocardiography before and after preoxygenation to evaluate the hemodynamic effects of different devices and PEEP.
|
Baseline and at the end of each 3-minute preoxygenation session
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Airway pressure during breath-holding maneuver
時間枠:Immediately following the preoxygenation session with bag-valve mask (with or without PEEP)
|
Airway pressure generated during a brief voluntary breath-holding maneuver will be measured when oxygen is delivered via nasal cannula under a bag-valve mask (with or without PEEP), to assess potential continuous positive airway pressure generation.
|
Immediately following the preoxygenation session with bag-valve mask (with or without PEEP)
|
協力者と研究者
捜査官
- 主任研究者:Simon Rauch、Eurac research, Institute of mountain emergency medicine
出版物と役立つリンク
一般刊行物
- Roveri G, Camporesi A, Hofer A, Kahlen S, Breidt F, Rauch S. Preoxygenation With and Without Positive End-Expiratory Pressure in Lung-Healthy Volunteers: A Randomized Clinical Trial. JAMA Netw Open. 2025 May 1;8(5):e2511569. doi: 10.1001/jamanetworkopen.2025.11569.
- Rauch S, Pietsch U, Roveri G. Preoxygenation in prehospital critical care: a survey of HEMS practices in eight European countries. Emerg Med J. 2026 Jan 16:emermed-2025-215335. doi: 10.1136/emermed-2025-215335. Online ahead of print. No abstract available.
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- PREOXY II
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Nasal cannula (NC)の臨床試験
-
Children's Hospital of Eastern OntarioDr. Noze Best LLC完了
-
Laboratoires Quinton International S.L.まだ募集していませんアレルギー性鼻炎 | 鼻詰まり | 風邪 | 副鼻腔炎 | インフルエンザの症状スペイン
-
Fisher and Paykel Healthcare完了
-
University of HelsinkiFinnish Cultural Foundation; University of Oulu; Finnish Work Environment Fund; Juho Vainio Foundation と他の協力者わからない
-
VistaGen Therapeutics, Inc.募集
-
Deutsches Herzzentrum MuenchenSIS Medical AG完了
-
Nanjing First Hospital, Nanjing Medical University完了